In reading several of the most recent headlines involving Roche, it is clear that this company is building momentum.
can you elaborate?
They have been testing an asthma treatment that has shown many promising results. Lebrikizumab has been effective in many of its tests. With an already approved and widely used Xonair, librikizumab would increase the exposure of Roche.